SKYSTAR BIO-PHARMACEUTICAL CO

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$2.3M

17 transactions

Summary

SKYSTAR BIO-PHARMACEUTICAL CO is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.4MSales: —8 insiders

Date	Insider	Type	Value
2012-05-04	LU WEIBING(Chief Executive Officer)	A	$602K
2014-12-10	GREGORY JOHN M	Buy	$470K
2014-12-23	GREGORY JOHN M	Buy	$303K
2015-05-26	GREGORY JOHN M	Buy	$186K
2015-05-06	GREGORY JOHN M	Buy	$174K
2015-02-02	GREGORY JOHN M	Buy	$163K
2015-04-16	GREGORY JOHN M	Buy	$134K
2012-05-04	WEN WEI(Vice President, Secretary)	A	$108K
2012-05-04	Chen Mark D	A	$54K
2012-05-04	Mei Bing(Chief Financial Officer)	A	$46K
2012-05-04	Fan Qiang	A	$26K
2012-05-04	SHEN WEIRONG	A	$5K
2014-03-10	LU WEIBING(Chief Executive Officer)	A	—
2014-03-10	Mei Bing(Chief Financial Officer)	A	—
2009-05-26	TCHAIKOVSKY BENNET PRICE JR(Chief Financial Officer)	A	$0
2009-05-26	Chen Mark D	A	$0
2008-05-05	TCHAIKOVSKY BENNET PRICE JR(Chief Financial Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

SKYSTAR BIO-PHARMACEUTICAL CO — Contributions, Lobbying & Contracts | Poliscope